217 related articles for article (PubMed ID: 26770215)
1. BMI1, ALDH1A1, and CD133 Transcripts Connect Epithelial-Mesenchymal Transition to Cancer Stem Cells in Lung Carcinoma.
Koren A; Rijavec M; Kern I; Sodja E; Korosec P; Cufer T
Stem Cells Int; 2016; 2016():9714315. PubMed ID: 26770215
[TBL] [Abstract][Full Text] [Related]
2. TWIST1 and BMI1 in Cancer Metastasis and Chemoresistance.
Ren H; Du P; Ge Z; Jin Y; Ding D; Liu X; Zou Q
J Cancer; 2016; 7(9):1074-80. PubMed ID: 27326250
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of cancer stem cells, epithelial-mesenchymal transition and circulating tumor cells in lung cancer.
Pirozzi G; Tirino V; Camerlingo R; La Rocca A; Martucci N; Scognamiglio G; Franco R; Cantile M; Normanno N; Rocco G
Oncol Rep; 2013 May; 29(5):1763-8. PubMed ID: 23426441
[TBL] [Abstract][Full Text] [Related]
4. Ionizing Radiation Promotes Epithelial-Mesenchymal Transition Phenotype and Stem Cell Marker in The Lung adenocarcinoma: In Vitro and Bioinformatic Studiesc.
Raei M; Bagheri M; Aghaabdollahian S; Ghorbani M; Sadeghi A
Cell J; 2022 Sep; 24(9):522-530. PubMed ID: 36274205
[TBL] [Abstract][Full Text] [Related]
5. Relationship between circulating tumor cells and epithelial to mesenchymal transition in early breast cancer.
Mego M; Cierna Z; Janega P; Karaba M; Minarik G; Benca J; Sedlácková T; Sieberova G; Gronesova P; Manasova D; Pindak D; Sufliarsky J; Danihel L; Reuben JM; Mardiak J
BMC Cancer; 2015 Jul; 15():533. PubMed ID: 26194471
[TBL] [Abstract][Full Text] [Related]
6. CSC-3436 inhibits TWIST-induced epithelial-mesenchymal transition via the suppression of Twist/Bmi1/Akt pathway in head and neck squamous cell carcinoma.
Lai YJ; Yu WN; Kuo SC; Ho CT; Hung CM; Way TD; Chen CT
J Cell Physiol; 2019 Jun; 234(6):9118-9129. PubMed ID: 30341909
[TBL] [Abstract][Full Text] [Related]
7. BMI1-Mediated Pemetrexed Resistance in Non-Small Cell Lung Cancer Cells Is Associated with Increased SP1 Activation and Cancer Stemness.
Shen HT; Chien PJ; Chen SH; Sheu GT; Jan MS; Wang BY; Chang WW
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32726929
[TBL] [Abstract][Full Text] [Related]
8. CXCR4 is involved in CD133-induced EMT in non-small cell lung cancer.
Tu Z; Xie S; Xiong M; Liu Y; Yang X; Tembo KM; Huang J; Hu W; Huang X; Pan S; Liu P; Altaf E; Kang G; Xiong J; Zhang Q
Int J Oncol; 2017 Feb; 50(2):505-514. PubMed ID: 28000861
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Bmi‑1 promotes epithelial‑mesenchymal transition in CD133+Hep G2 cells.
Zhang Z; Wang Q; Bu X; Zhang C; Chen H; Sha W; Liu W
Mol Med Rep; 2017 Nov; 16(5):6156-6161. PubMed ID: 28849237
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal circulating tumor cells (CTCs) and OCT4 mRNA expression in CTCs for prognosis prediction in patients with non-small-cell lung cancer.
Li S; Chen Q; Li H; Wu Y; Feng J; Yan Y
Clin Transl Oncol; 2017 Sep; 19(9):1147-1153. PubMed ID: 28374320
[TBL] [Abstract][Full Text] [Related]
11. Breast tumor cell-specific knockout of
Xu Y; Lee DK; Feng Z; Xu Y; Bu W; Li Y; Liao L; Xu J
Proc Natl Acad Sci U S A; 2017 Oct; 114(43):11494-11499. PubMed ID: 29073077
[TBL] [Abstract][Full Text] [Related]
12. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
Geng S; Guo Y; Wang Q; Li L; Wang J
Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
[TBL] [Abstract][Full Text] [Related]
13. Novel antibody reagents for characterization of drug- and tumor microenvironment-induced changes in epithelial-mesenchymal transition and cancer stem cells.
Navas T; Pfister TD; Colantonio S; Aziz A; Dieckman L; Saul RG; Kaczmarczyk J; Borgel S; Alcoser SY; Hollingshead MG; Lee YH; Bottaro DP; Hiltke T; Whiteley G; Takebe N; Kinders RJ; Parchment RE; Tomaszewski JE; Doroshow JH
PLoS One; 2018; 13(6):e0199361. PubMed ID: 29928062
[TBL] [Abstract][Full Text] [Related]
14. Assessment of cancer stem cell marker expression in primary head and neck squamous cell carcinoma shows prognostic value for aldehyde dehydrogenase (ALDH1A1).
Szafarowski T; Sierdziński J; Ludwig N; Głuszko A; Filipowska A; Szczepański MJ
Eur J Pharmacol; 2020 Jan; 867():172837. PubMed ID: 31811857
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of long non-coding RNA linc-ITGB1 inhibits cancer stemness and epithelial-mesenchymal transition by reducing the expression of Snail in non-small cell lung cancer.
Guo L; Sun C; Xu S; Xu Y; Dong Q; Zhang L; Li W; Wang X; Ying G; Guo F
Thorac Cancer; 2019 Feb; 10(2):128-136. PubMed ID: 30485693
[TBL] [Abstract][Full Text] [Related]
16. TMPRSS4 induces cancer stem cell-like properties in lung cancer cells and correlates with ALDH expression in NSCLC patients.
de Aberasturi AL; Redrado M; Villalba M; Larzabal L; Pajares MJ; Garcia J; Evans SR; Garcia-Ros D; Bodegas ME; Lopez L; Montuenga L; Calvo A
Cancer Lett; 2016 Jan; 370(2):165-76. PubMed ID: 26546046
[TBL] [Abstract][Full Text] [Related]
17. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
[TBL] [Abstract][Full Text] [Related]
18. Fisetin suppresses migration, invasion and stem-cell-like phenotype of human non-small cell lung carcinoma cells via attenuation of epithelial to mesenchymal transition.
Tabasum S; Singh RP
Chem Biol Interact; 2019 Apr; 303():14-21. PubMed ID: 30802432
[TBL] [Abstract][Full Text] [Related]
19. Clinical Relevance of a Candidate Stem Cell Marker, p75 Neurotrophin Receptor (p75NTR) Expression in Circulating Tumor Cells.
Okumura T; Yamaguchi T; Watanabe T; Nagata T; Shimada Y
Adv Exp Med Biol; 2017; 994():247-254. PubMed ID: 28560678
[TBL] [Abstract][Full Text] [Related]
20. Expression Patterns for
Atlasy N; Amidi F; Mortezaee K; Fazeli MS; Mowla SJ; Malek F
Avicenna J Med Biotechnol; 2019; 11(2):156-161. PubMed ID: 31057717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
